Page last updated: 2024-09-03

heptakis(2,6-o-dimethyl)beta-cyclodextrin and tadalafil

heptakis(2,6-o-dimethyl)beta-cyclodextrin has been researched along with tadalafil in 1 studies

Compound Research Comparison

Studies
(heptakis(2,6-o-dimethyl)beta-cyclodextrin)
Trials
(heptakis(2,6-o-dimethyl)beta-cyclodextrin)
Recent Studies (post-2010)
(heptakis(2,6-o-dimethyl)beta-cyclodextrin)
Studies
(tadalafil)
Trials
(tadalafil)
Recent Studies (post-2010) (tadalafil)
1480451,7423921,089

Protein Interaction Comparison

ProteinTaxonomyheptakis(2,6-o-dimethyl)beta-cyclodextrin (IC50)tadalafil (IC50)
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.0012
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.0012
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.0012
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.0012
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.0012
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.0012
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.0012
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.0012
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.0012
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.0012
Chain A, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.0012
Chain B, cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.0012
Chain A, cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)0.0012
Chain A, cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)0.0012
cGMP-dependent 3',5'-cyclic phosphodiesteraseHomo sapiens (human)3.0704
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit deltaHomo sapiens (human)2.928
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8AHomo sapiens (human)3.0704
cGMP-specific 3',5'-cyclic phosphodiesteraseHomo sapiens (human)0.5153
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gammaBos taurus (cattle)5.1
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alphaBos taurus (cattle)4.05
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alphaHomo sapiens (human)2.928
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'Bos taurus (cattle)5.1
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gammaHomo sapiens (human)2.928
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gammaBos taurus (cattle)5.1
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit betaBos taurus (cattle)5.1
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)9.2
Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit betaHomo sapiens (human)2.928
Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'Homo sapiens (human)2.507
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1BHomo sapiens (human)3.0704
Synaptic vesicular amine transporterRattus norvegicus (Norway rat)0.012
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)4.6028
cAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)9.2
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)4.6028
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)3.0704
Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gammaHomo sapiens (human)2.928
cGMP-specific 3',5'-cyclic phosphodiesteraseBos taurus (cattle)0.0075
Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit deltaBos taurus (cattle)5.1
Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11AHomo sapiens (human)0.8575
cAMP-specific 3',5'-cyclic phosphodiesterase 7BHomo sapiens (human)3.0704
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10AHomo sapiens (human)3.0704

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Badr-Eldin, SM; Elkheshen, SA; Ghorab, MM1

Other Studies

1 other study(ies) available for heptakis(2,6-o-dimethyl)beta-cyclodextrin and tadalafil

ArticleYear
Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2008, Volume: 70, Issue:3

    Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; beta-Cyclodextrins; Calorimetry, Differential Scanning; Carbolines; Chemistry, Pharmaceutical; Crystallography, X-Ray; Drug Compounding; Excipients; Freeze Drying; Kinetics; Phosphodiesterase Inhibitors; Solubility; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Tablets; Tadalafil; Technology, Pharmaceutical

2008